Trials / Completed
CompletedNCT02549339
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 383 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the trial is to compare the short term efficacy of LEO 43204 gel with vehicle gel in AK on face or chest when applied topically once daily for 3 consecutive days as field treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 43204 gel | |
| DRUG | Vehicle gel |
Timeline
- Start date
- 2015-11-13
- Primary completion
- 2016-08-05
- Completion
- 2017-08-10
- First posted
- 2015-09-15
- Last updated
- 2025-03-10
- Results posted
- 2018-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02549339. Inclusion in this directory is not an endorsement.